US Stock MarketDetailed Quotes
ALLO Allogene Therapeutics
- 2.890
- +0.035+1.23%
Close Apr 26 16:00 ET
- 2.920
- +0.030+1.03%
Post 18:34 ET
493.39MMarket Cap-1382P/E (TTM)
2.930High2.750Low2.45MVolume2.870Open2.855Pre Close7.00MTurnover2.18%Turnover RatioLossP/E (Static)170.72MShares6.89052wk High0.96P/B325.56MFloat Cap2.23052wk Low--Dividend TTM112.65MShs Float55.000Historical High--Div YieldTTM6.31%Amplitude2.230Historical Low2.852Avg Price1Lot Size
Allogene Therapeutics Stock Analyst Ratings & Price Target
Price Target
Updated: Apr 8, 2024
The average Allogene Therapeutics stock price target is 13.23 with a max estimate of 35.00 and a min estimate of 4.40
Review Allogene Therapeutics earnings estimates
Detailed Ratings
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Download APP
Analyst Ratings Disclaimer
Analysis
Price Target
Updated: Apr 8, 2024
Heat List
US
Overall
Symbol
Latest Price
%Chg